12-53066360-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032840.3(SPRYD3):c.1148A>G(p.Glu383Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000131 in 152,106 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032840.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPRYD3 | NM_032840.3 | c.1148A>G | p.Glu383Gly | missense_variant | Exon 10 of 11 | ENST00000301463.9 | NP_116229.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPRYD3 | ENST00000301463.9 | c.1148A>G | p.Glu383Gly | missense_variant | Exon 10 of 11 | 1 | NM_032840.3 | ENSP00000301463.4 | ||
SPRYD3 | ENST00000547837.5 | c.1259A>G | p.Glu420Gly | missense_variant | Exon 11 of 12 | 5 | ENSP00000449452.1 | |||
SPRYD3 | ENST00000547257.1 | n.-2A>G | upstream_gene_variant | 5 | ENSP00000448845.1 | |||||
SPRYD3 | ENST00000537540.1 | n.*600A>G | downstream_gene_variant | 2 | ENSP00000446156.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152106Hom.: 0 Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152106Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74322
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1148A>G (p.E383G) alteration is located in exon 10 (coding exon 10) of the SPRYD3 gene. This alteration results from a A to G substitution at nucleotide position 1148, causing the glutamic acid (E) at amino acid position 383 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at